Innovate UK, under UK Research and Innovation, will grant up to £5 million for innovation projects focusing on flexible, agile, scalable and sustainable technologies (FASST) for medicines development and manufacture. Projects should boost manufacturing processes, increase efficiency, and reduce time-to-market, aiming for wider patient access to medicines. Proposals should benefit at least one UK SME's growth, productivity, and competitiveness.
Grant funding requests should range between £200,000 and £2 million.
Your project should:
Technologies in Scope:
Examples include laboratory automation, digital twins, predictive supply chain management, real-time release testing, continuous biomanufacturing, large scale manufacturing robots, AI decision support, sustainable platform processes, and data-driven biomanufacturing.
Focus areas include cost reduction, environmental impact minimization, patient access enhancement, yield and productivity boost, data processing speed, efficiency, market entry time reduction, development time minimization, process monitoring, supply chain data utilization, and commitment to skill development.
Industrial research and experimental development projects will be funded.
Projects focused only on medicine discovery won't be funded. Similarly, projects reliant on export performance or domestic input usage won't be eligible.